Literature DB >> 7572086

Coexistence of Pick bodies and atypical Lewy bodies in the locus ceruleus neurons of Pick's disease.

S Takauchi1, S Yamauchi, Y Morimura, K Ohara, Y Morita, S Hayashi, K Miyoshi.   

Abstract

We observed abundant Pick argentophilic inclusion bodies (PBs) as well as some atypical Lewy bodies (LBs) in the locus ceruleus (LC) from a patient with Pick's disease. In addition, there were a few neurons which contained both PBs and LBs. PBs in the LC frequently appeared multiple and had lobulated or irregular shapes, though their ultrastructural elements were the same as those of the PBs appearing in the cerebral cortex, and consisted of randomly arranged smooth-surfaced straight tubules of 15 nm in diameter, mixed with a small number of long-period constricted fibrils. The ultrastructure of the LB coexisting with PB was identical with that previously reported; a dense core was surrounded by concentric layers of radially oriented 10-nm filaments and was clearly distinguishable from the PB. Immunohistochemical examination with various antibodies related to neurofibrillar pathology demonstrated that anti-tau antibodies reacted positively with both PB and the rim portion of LB in the present case; an unusual finding for LB. The anti-neurofilament 200-kDa protein stained only LBs, even when PBs and LBs coexisted in the same neuron. These findings show that two kinds of neuronal fibrillar inclusions, whose underlying cytoskeletal abnormalities are thought to be different, can coexist in the same neuron. In addition, the formation of multiple, lobulated PBs may suggest some particularity of cytoskeletal composition of the LC neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572086     DOI: 10.1007/BF00294465

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments.

Authors:  L S Forno; L A Sternberger; N H Sternberger; A M Strefling; K Swanson; L F Eng
Journal:  Neurosci Lett       Date:  1986-03-14       Impact factor: 3.046

2.  Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments.

Authors:  M S Pollanen; C Bergeron; L Weyer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 3.  Pathology and biology of the Lewy body.

Authors:  M S Pollanen; D W Dickson; C Bergeron
Journal:  J Neuropathol Exp Neurol       Date:  1993-05       Impact factor: 3.685

4.  Immunocytochemical and ultrastructural studies of Pick's disease.

Authors:  S Murayama; H Mori; Y Ihara; M Tomonaga
Journal:  Ann Neurol       Date:  1990-04       Impact factor: 10.422

5.  The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease.

Authors:  P G Galloway; C Bergeron; G Perry
Journal:  Neurosci Lett       Date:  1989-05-22       Impact factor: 3.046

6.  Pick bodies in the locus ceruleus.

Authors:  L S Forno; L F Eng; D J Selkoe
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

7.  Neurofibrillary tangles and Lewy bodies in the locus ceruleus neurons of the aged brain.

Authors:  M Tomonaga
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

8.  Lewy bodies in cerebral cortex, report of three cases.

Authors:  K Kosaka
Journal:  Acta Neuropathol       Date:  1978-05-24       Impact factor: 17.088

9.  New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies.

Authors:  P N Leigh; A Probst; G E Dale; D P Power; J P Brion; A Dodson; B H Anderton
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles.

Authors:  P G Galloway; I Grundke-Iqbal; K Iqbal; G Perry
Journal:  J Neuropathol Exp Neurol       Date:  1988-11       Impact factor: 3.685

View more
  1 in total

Review 1.  Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease.

Authors:  David Weinshenker
Journal:  Trends Neurosci       Date:  2018-02-20       Impact factor: 13.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.